Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
127
天
Expiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities
作者
Grazia Crescimanno; Oreste Marrone; Marta Lazzeri; Paolo Innocente Banfi; Agata Lax; Elena Compalati; Rosario Di Marco; Sabrina Planiscig; Paola Confalonieri; Fabrizio Seidita; Filippo Brighina; Marco Confalonieri展开收起
作者单位
1. Institute for Biomedical Research and Innovation (IRIB), National Research Council, Palermo, Italy; 2. Departmental Unit of Neurophysiopathology, Regional Centre for Diagnosis and Treatment of Rare Neurological Diseases, AOUP Policlinico, University of Palermo, Palermo, Italy; 3. IRCCS Fondazione Don Gnocchi, Milano, Italy; 4. Functional Recovery and Rehabilitation, Ospedali Riuniti Villa Sofia- Cervello, Palermo, Italy; 5. Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy; 6. AIGlico (Italian Glycogenosis Association), Assago, Italy展开收起
140
天
Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet–Biedl Syndrome: a pilot study
作者
Tugce Kandemir; Melek Yildiz; Ummahan Tercan; Ozge Bayrak Demirel; Hasan Yanik; Volkan Karaman; Ayca Dilruba Aslanger; Aslı Derya Kardelen; Sukran Poyrazoglu; Feyza Darendeliler; Guven Toksoy; Firdevs Bas展开收起
作者单位
1. Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye; 2. Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye; 3. Department of Genetics, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye展开收起
391
天
Management of patients with rare diseases in the Middle East: challenges & opportunities – insights from the Rare Advocacy Council
作者
Agnès Farrugia; Ahmed Bahey; Ahmad Tarawah; Arwa Al Yamani; Carla Abou Selwan; Dania Mohty; Denis Wolfs; Dorica Dan; Hafiz Mosa Ali Malhan; Johan De Graaf; Stefan Živković; Yasser Wali; Youmna Ouraybi; Zakareya Al Kadhem; Nafisa Tawfiq; Lee Davelaar; Noha Mohamed Mahmoud Abdelbaky展开收起
作者单位
1. Association Française Contre L’Amylose, Marseille, France; 2. Qatar Friends Hemophilia Group (QFHG), Doha, Qatar; 3. Pediatric Hematology-Oncology, King Salman Medical City, Madinah, Saudi Arabia; 4. Al Madinah Hereditary Blood Disorders Charity Society, Madinah, Saudi Arabia; 5. MENA Hematology League, Dubai, United Arab Emirates; 6. Hematology/Oncology/BMT Deputy Chairman of Saudi and Thalassemia and Sickle Cell Anemia Society, Riyadh, Saudi Arabia; 7. Saudi Association of Pediatric Hematology/Oncology Society (SAPHOS), Riyadh, Saudi Arabia; 8. Science PRO, Jal-el-dib, Lebanon; 9. King Faisal Specialist Hospital, Riyadh, Saudi Arabia; 10. Amyloidosis Association, Brussels, Belgium; 11. Romanian National Alliance for Rare Disease, Bucharest, Romania; 12. Adult Hematologist, Riyadh, Saudi Arabia; 13. Dutch Pituitary Foundation, Nijkerk, The Netherlands; 14. Endo-ERN European Reference Network on Rare Endocrine Conditions, Leiden, The Netherlands; 15. Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands; 16. National Organization of Rare Diseases, Belgrade, Serbia; 17. Pediatric Hematology, College of Medicine and Health Sciences, Sultan Qaboos University, Board Member Omani Society of Hematology, Muscat, Oman; 18. Ana Fareed Health Consultancy for Patient Advocacy, Dubai, United Arab Emirates; 19. Bahrain Society for Sickle Cell Disease Patients Care, Manama, Bahrain; 20. UAE Rare Disease Society, Dubai, United Arab Emirates; 21. Emerging Markets, Global Policy & Public Affairs, Rare Diseases, Pfizer, Sydney, Australia; 22. Regional Patient Advocacy – Middle East, Pfizer, Cairo, Egypt展开收起
72
天
Defining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement
作者
Benedikt Schoser展开收起
作者单位
1. Department of Neurology, Friedrich-Baur-Institute, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, München, Germany展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天